Skip to main content
. 2021 Oct 19;13(10):3666. doi: 10.3390/nu13103666

Table 4.

SCFAs promote adipogenesis and browning of adipose tissue.

Experimental Design Cell or Tissue Type Outcome Study
5 mM butyrate for up to 7 days. 3T3-L1 ↑ Adipogenesis
↑ Lipid droplets
↑ LPL, aP2 mRNA expression
Toscani et al. 1990 [153]
0.1–1.5 mM butyrate for up to 9 days. Porcine stromal vascular ↑ adipogenesis
↑ C/EBPα/β, PPAR-γ, SREBP-1c mRNA
Yan et al. 2015 [54]
0.1–3 mM butyrate and propionate on day 10 of differentiation. Porcine stromal vascular ↑ Adipogenesis
↑ C/EBPα/β, PPAR-γ mRNA
Li et al. 2014 [50]
6.4 mM acetate, 3.2 mM propionate, 0.8 mM butyrate for 10 days. 3T3-L1 ↑ Adipogenesis
↑ FAS, FATP4, aP2, LPL mRNA
Yu et al. 2018 [154]
0.1 μmol/L acetate for 7 days. 3T3-L1 ↑ Adipogenesis
↑ PPAR-γ2 mRNA
Hong et al. 2005 [78]
8 mM propionate and butyrate ~11 days. SGBS No effects on adipogenesis or adipogenic markers Alex et al. 2013 [155]
0.01–0.1 mM propionate for 8 days. Broiler adipocytes No effects on adipogenesis
↓ aP2, PPAR-γ mRNA
Li et al. 2021 [156]
Plasma acetate measurement SAT and VAT adipose tissue ↑ Browning adipogenesis
↑ PRDM 16, UCP1, DIO2 mRNA
Moreno-Navarrete et al. 2018 [146]
10 mM acetate for up to 7 days. IM-BAT ↑ Browning adipogenesis
↑ Mitochondrial biogenesis
↑ PGC-1α, PPAR-γ, aP2, UCP-1 mRNA
Hu et al. 2016 [84]
1 mM acetate
0.6% acetate in drinking water for 16 weeks.
3T3-L1
KK-Ay mice
↑ Browning adipogenesis
↑ CIDEA, TMEM26, TBX1, FABP4, PPAR-γ, PRDM16, UCP-1, DIO2 mRNA
Hanatani et al. 2016 [51]
5% wt wt−1 acetate, propionate, butyrate or mixture SCFA supplemented (3:1:1 ratio) in high-fat diet for 16 weeks. C57Bl/6J mice ↑ Browning adipogenesis
↑ PGC-1α, NRF-1, Tfam, β-F1 ATPase, COX IV, cyt-c
Lu et al. 2016 [17]

Relevant studies were identified using PubMed query searches for “short-chain fatty acids” OR “acetate” OR “propionate” OR “butyrate” AND “adipocyte” OR “3T3-L1” AND “adipogenesis” OR “browning”. Eleven studies examining the effects of SCFAs on adipocyte adipogenesis and/or browning were thus identified. Abbreviations—aP2: adipocyte fatty-acid-binding protein; β-F1: b subunit of the mitochondrial H+- ATP synthase; C/EBPα/β: CCAAT- enhancer-binding proteins; CIDEA: cell-death-inducing DNA fragmentation factor-α-like effector A; COX IV: cytochrome c oxidase IV; cyt-c: cytochrome c somatic; SGBS: human Simpson–Golabi–Behmel syndrome cells; DIO2: iodothyrinine deiodinase 2; FAS: fatty acid synthase; FATP4: fatty acid transporter protein 4; LPL: lipoprotein lipase; NRF: nuclear respiratory factor 1; PPAR-γ: peroxisome proliferator-activated receptor gamma; PRDM16: PR domain containing 16; SREBP-1c: sterol regulatory element-binding protein 1c; TBX1: T-box transcription factor 1; Tfam: mitochondrial transcription factor A; TMEM26: transmembrane protein 26; UCP1: uncoupling protein; SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue; IM-BAT: immortalized brown adipocyte cells. ↑: increased; ↓: decreased.